Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million

Core Viewpoint - Pluri Inc. has successfully secured a total of $10 million in strategic investments over the past two weeks, including a recent $3.5 million private placement from Merchant Adventure Fund, reinforcing confidence in the company's growth strategy and technology [3][4][9]. Investment Details - The company has agreed to issue 759,219 shares at a price of $4.61 per share, along with warrants for 45,553 shares at an exercise price of $5.568, resulting in gross proceeds of $3.5 million [2]. - The closing of this offering is expected around February 20, 2025, pending customary closing conditions [2]. Strategic Implications - The recent investments are intended to support Pluri's growth as a global leader in cell-based technology, with applications across various industries such as pharmaceuticals, food technology, and agriculture technology [4][5]. - The company is also pursuing an agreement to acquire Kokomodo Ltd., which may allow entry into the cacao market, subject to shareholder approval [3]. Company Overview - Pluri Inc. is focused on creating cell-based products for commercial use, utilizing a patented 3D cell expansion system to address challenges in medicine, climate change, food scarcity, and animal welfare [8]. - The company operates in regenerative medicine, food technology, and agriculture technology, and offers Contract Development and Manufacturing Organization services [8].